http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1467407-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20
filingDate 1974-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1467407-A
titleOfInvention Process for the manufacture of 7-beta-acylaminoceph-3-em- 4-carboxylic acid compounds
abstract 1467407 7 - Acylamino - ceph - 3 - em - 4- carboxylic acids and derivatives thereof CIBAGEIGY AG 28 March 1974 [30 March 1973] 13720/74 Heading C2C Novel compounds of the Formula I wherein X is sulphur or oxygen, R is hydrogen or an amino protective group, R 1 is hydrogen, a free etherified or esterified hydroxyl or mercapto group, or a substituted ammonium group, R 2 is hydroxyl or a carboxyl protective radical which together with the carbonyl grouping of the formula -C(: O)- forms a protected carboxyl group, or salts thereof, may be prepared by acylating a compound of the Formula II wherein the amino group is optionally substituted by a group which permits acylation to take place, or a salt thereof with carboxylic of the Formula III or a reactive derivative thereof and optionally removing or interconverting protective groups at R and R 2 , converting R 1 groups to other R 1 groups and forming salts or free compounds. 2 - (5 - N - tert. - Butoxycarbonylaminomethyl- 2-thienyl acetic acid is prepared by reacting thenylamine hydrochloride with trifluoroacetic acid and acetic anhydride to form 2-acetyl-5- trifluoroacetylaminomethyl-thiophene which with perchloric acid, thallium nitrate and methanol yields 2 - (5 - trifluoroacetylaminomethyl - 2- thienyl) acetic acid, methyl ester which with base and then t-butoxycarbonyl azide yields the required compound. 2-(5-N-t-Butoxycarbonylamino-2-furyl) acetic acid is prepared by an analogous process from furfurylamine. 2-Acetyl- 5 - trifluoroacetylaminomethyl - thiophene is also prepared by reacting thiophene with N- hydroxymethyltrifluoroacetamide in trifluoroacetic acid and acetic anhydride. Pharmaceutical compositions of the compounds I in which R is hydrogen and R 2 is hydroxyl or a radical which together with the carbonyl grouping of the formula -C(=O)- forms an esterified carbonyl group which can be split under physiological conditions or a physiologically acceptable salt thereof, with the usual excipients show antibiotic activity when administered orally or parenterally.
priorityDate 1973-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23330361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410438213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423105479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414806902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12752924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420957828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448951191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20449092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414392184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529141

Total number of triples: 59.